23.04.2014 Views

International Financial Reporting Standards_guide.pdf

International Financial Reporting Standards_guide.pdf

International Financial Reporting Standards_guide.pdf

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

312 Chapter 29 Share-Based Payment (IFRS 2)<br />

29.4.10 If the equity instruments granted do not vest until the counterparty completes a<br />

specified period of service, the amount recognized should be adjusted over any vesting<br />

period for changes in the estimate of the number of securities that will be issued (referred to<br />

as the true up calculation), but not for changes in the fair value of those securities. Therefore,<br />

on the vesting date, the amount recognized is the exact number of securities that can be<br />

issued as of that date, measured at the fair value of those securities at grant date.<br />

29.4.11 If the entity cancels or settles a grant of equity instruments during the vesting<br />

period (other than a grant canceled by forfeiture when the vesting conditions are not satisfied),<br />

the following accounting requirements apply:<br />

■ The entity accounts for the cancellation or settlement as an acceleration of vesting by<br />

recognizing immediately the amount that otherwise would have been recognized over<br />

the remainder of the vesting period.<br />

■ The entity recognizes in equity any payment made to the employee on the cancellation<br />

or settlement to the extent that the payment does not exceed the fair value at the repurchase<br />

date of the equity instruments granted.<br />

■ The entity recognizes as an expense the excess of any payment made to the employee<br />

on the cancellation or settlement over the fair value at the repurchase date of the equity<br />

instruments granted.<br />

■ The entity accounts for new equity instruments granted to the employee as replacements<br />

for the cancelled equity instruments as a modification of the original grant. The<br />

difference between the fair value of the replacement equity instruments and the net fair<br />

value of the cancelled equity instruments at the date the replacement equity instruments<br />

are granted is recognized as an expense.<br />

Cash-Settled Share-Based Payment Transaction<br />

Recognition<br />

29.4.12 An entity should recognize the goods or services received or acquired in a sharebased<br />

payment transaction when it obtains the goods or as the services are received. For<br />

cash-settled share-based payment transactions, the corresponding credit should be recognized<br />

as a liability.<br />

Measurement<br />

29.4.13 The goods and services received and the liability incurred should be measured at<br />

the fair value of the liability. Until the liability is settled, the entity should remeasure the fair<br />

value of the liability at each reporting date and at the date of settlement, with any changes in<br />

fair value recognized in profit or loss for the period.<br />

29.4.14 If the share-based payment granted does not vest until the counterparty completes<br />

a specified period of service, the amount recognized should be adjusted over any vesting<br />

period for changes in the estimate of the number of benefits expected to vest (referred to as<br />

the true up calculation) and for changes in the fair value of those securities.<br />

29.4.15 If the entity cancels or settles a grant a cash-settled grant, the same principles as<br />

discussed in 29.4.11 should be applied.<br />

Share-Based Payment Transactions with Cash Alternatives<br />

29.4.16 For share-based payment transactions in which the terms of the arrangement provide<br />

either the entity or the counterparty with the choice of settlement either in cash (or other

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!